Screener / SEC EDGAR /CIK 0001821825 /10-K filed Feb 24, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Pharmaceuticals

Organon & Co. OGN

Compare with peers Embed
Cash returned and share count

No buyback or stock pay figures in its 10-K data yet

XBRL, 10-K

Where the cash came from and where it went

FY2025, from the cash flow statement in the 10-K, added up

Operating cash flowDebt raisedCash on hand usedCapital spendingDividendsDebt repaidOther, net Operating cash flow: $700.0M Operating cash flow $700.0M Debt raised: $1.1B Debt raised $1.1B Cash on hand used: $101.0M Cash on hand used $101.0M Capital spending: $162.0M Capital spending $162.0M Dividends: $88.0M Dividends $88.0M Debt repaid: $1.5B Debt repaid $1.5B Other, net: $93.0M Other, net $93.0M

Each number is a line of the cash flow statement as the company tagged it. "Other, net" is what those lines do not cover (investments bought and sold, other financing and investing lines, and exchange rates); Tickdelta does not estimate it.

Where the operating cash went, year by year

FY2019 to FY2025 · cash flow statements, 10-K XBRL

7 years
Operating cash, added up $10.8B 7 fiscal years, FY2019 to FY2025
Reinvested 12% capital spending and acquisitions, as a share of that cash
Returned to owners 10% buybacks and dividends, as a share of that cash
Debt repaid $3.3B gross repayments added up; debt that was refinanced counts each time
Fiscal yearOperating cashCapital spendingDividendsDebt repaid
Dec 31, 2025 $700.0M $162.0M$88.0M$1.5B
Dec 31, 2024 $939.0M $175.0M$297.0M$1.2B
Dec 31, 2023 $799.0M $251.0M$294.0M$338.0M
Dec 31, 2022 $858.0M $196.0M$290.0M$108.0M
Dec 31, 2021 $2.2B $192.0M$145.0M$112.0M
Dec 31, 2020 $2.3B $255.0M--
Dec 31, 2019 $3.0B $92.0M--
Added up$10.8B $1.3B
12% of operating cash
$1.1B
10% of operating cash
$3.3B
30% of operating cash

Each bar is one fiscal year; its colours add up to what the cash flow statement says the company spent on each line, and the line across it is that year's operating cash flow. Spending above the line was paid from new debt, shares sold or cash on hand. A bar part links to the 10-K it comes from. A line the company did not report is left out, not estimated, so the shares are of operating cash only and can add up to more or less than 100%. Debt repaid is the gross amount, so refinanced debt is counted each time it is repaid. A reading aid, not a grade: Tickdelta does not say whether a split was good. Banks and insurers are left out.

Buybacks, dividends and share count

Year by year · XBRL, each 10-K

No buyback or share count data in the 10-K XBRL.

Dividend per share, year by year

Dividends · declared per share, each 10-K; cash paid, cash flow statement

Per share, FY2025 $0.34 declared in the fiscal year to Dec 31, 2025
Against the year before ▼-69.6% dividend per share
Years in a row raised 0 no raise in the latest year
Cash paid out - cash flow statement, FY2025
Years paid in a row 5 fiscal years, to FY2025, dividend per share above zero
Growth a year, FY2021 to FY2025 -11.7% $0.56 to $0.34 per share, 4 years

Declared since the 10-K: Sep 30, 2026 $0.02Jun 30, 2026 $0.02Mar 31, 2026 $0.02

Fiscal year toPer shareAgainst year beforeCash paid out
Dec 31, 2025 $0.34 ▼-69.6% -
Dec 31, 2024 $1.12 0.0% -
Dec 31, 2023 $1.12 0.0% -
Dec 31, 2022 $1.12 ▲+100.0% -
Dec 31, 2021 $0.56 - -

Dividend per share as the company tagged it (CommonStockDividendsPerShareDeclared), from the latest 10-K that reports each year, so a stock split is already in it. A change is left blank when the year before is missing or the jump is more than five times.

What the 10-Ks show for each CEO's years

Each CEO's years · the CEO of each fiscal year as named in the proxy's pay versus performance table

Joseph Morrissey

FY2025 · 1 year in the table
Operating cash flow
$700.0M
Capital spending
$162.0M
Dividends
$88.0M
Stock-based pay
$77.0M
Diluted shares since FY2024
+0.6%
Revenue since FY2024
-3%
Debt since FY2024
-$220.0M
CEO pay (reported)
$21.6M
The proxy that names the CEO

Kevin Ali

FY2021 to FY2024 · 4 years in the table
Operating cash flow
$4.8B
Capital spending
$814.0M
Dividends
$1.0B
Stock-based pay
$340.0M
Diluted shares since FY2020
+2.2%
Revenue since FY2020
-2%
Debt since FY2020
+$8.9B
CEO pay (reported)
$64.0M
The proxy that names the CEO

Sources

The cash flow statement, dividends per share and diluted share count in each 10-K's XBRL; Part II Item 2 of each 10-Q for monthly buybacks; offering prospectuses (S-3, 424B) for new shares; Form D data sets for private raises.

Also

CEO pay: what the CEO was paid over the same years.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/OGN/export.csv") into a cell.

Next:CEO pay
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.